Xu Zhenyu 4
4 · SOPHiA GENETICS SA · Filed Apr 10, 2026
Research Summary
AI-generated summary of this filing
SOPHiA GENETICS (SOPH) CSO Zhenyu Xu Sells Shares
What Happened
Zhenyu Xu, Chief Scientific Officer of SOPHiA GENETICS (SOPH), sold a total of 4,736 shares in two open-market transactions to satisfy tax withholding related to recent restricted stock unit (RSU) vesting. On 2026-04-08 he sold 2,800 shares at an average price of $4.84 for $13,549, and on 2026-04-09 he sold 1,936 shares at an average price of $4.74 for $9,176 (aggregate proceeds ≈ $22,725). These were sales (not purchases) and were executed pursuant to a pre-established Rule 10b5-1 plan.
Key Details
- Transaction dates and reported prices:
- 2026-04-08: 2,800 shares sold at $4.84 each (reported value $13,549). (Price range for related trades: $4.79–$4.92; details available on request.)
- 2026-04-09: 1,936 shares sold at $4.74 each (reported value $9,176). (Reported weighted-average price; executed in multiple trades at prices ranging $4.61–$4.87; details available on request.)
- Total shares sold: 4,736; total reported proceeds ≈ $22,725.
- Purpose: Sales were made to satisfy tax withholding obligations from RSU vestings on April 2 and 3, 2026, and were effected under a pre-established Rule 10b5-1 trading plan (non‑discretionary).
- Shares owned after the transactions: Not specified in this filing.
- Filing timeliness: Reported on 2026-04-10 for transactions on 2026-04-08 and 2026-04-09 — the Form 4 appears to be timely (not marked late).
Context
These sales were tax-withholding dispositions tied to RSU vesting and executed under a 10b5-1 plan, which are routine and typically do not signal a change in the insider's view of the company. Retail investors generally place more informational weight on insider purchases; routine withholding sales like these are common after equity vesting events.
Insider Transaction Report
- Sale
Ordinary Shares
[F1][F2]2026-04-08$4.84/sh−2,800$13,549→ 642,152 total - Sale
Ordinary Shares
[F1][F3]2026-04-09$4.74/sh−1,936$9,176→ 640,216 total
Footnotes (3)
- [F1]Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 2 and 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted by the Reporting Person and do not represent discretionary trades.
- [F2]prices ranging from $4.79 to $4.92, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.61 to $4.87, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.